AMPAC Fine Chemicals (AFC) revealed their ongoing facilities expansion both in Rancho Cordova, CA and La Porte, TX has served to increase total capacities by 50% since 2013. AFC reports the most recent high potency facility—Semi-Works #4—is fully operational and they have started construction of a large-scale facility that will come on-line in late 2016.

“AFC is witnessing robust customer demand for our core technologies combined with our development and manufacturing expertise to support drug candidate maturation from clinical trials into commercial production,” said Aslam Malik, chief executive officer, AMPAC Fine Chemicals. “To meet this demand, we are investing over $40 million in 2016 for capacity expansion and infrastructure enhancements.”

The company reports the new facilities add nine reactors—500-2000 gal—Heinkel Hastelloy (HF-800) centrifuges plus additional solids handing and processing equipment necessary to support on-going production of cGMP intermediates and APIs.

“These two facilities benefit from AFC’s extensive experience in elimination of Foreign Object & Debris (FOD) and containment of potent compounds,” said Joseph Campbell, vice president of operations and engineering, AMPAC.